Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib.
暂无分享,去创建一个
R. Green | J. Brandt | S. Piantadosi | Denis A. Evans | S. Craft | C. Szekely | J. Breitner | M. Mullan | B. Martin
[1] R. Green,et al. Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial , 2007, Neurology.
[2] L. Thal,et al. A Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive Impairment , 2005, Neuropsychopharmacology.
[3] S. Goodman,et al. Nonsteroidal Anti-Inflammatory Drugs for the Prevention of Alzheimer’s Disease: A Systematic Review , 2004, Neuroepidemiology.
[4] C. Lines,et al. Rofecoxib , 2004, Neurology.
[5] K. Davis,et al. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. , 2003, JAMA.
[6] P. Zandi,et al. Reduced incidence of AD with NSAID but not H2 receptor antagonists: The Cache County Study , 2002, Neurology.
[7] Tony Wyss-Coray,et al. Inflammation in Neurodegenerative Disease—A Double-Edged Sword , 2002, Neuron.
[8] P. Aisen,et al. Randomized pilot study of nimesulide treatment in Alzheimer’s disease , 2002, Neurology.
[9] C. Meinert,et al. Double placebo design in a prevention trial for Alzheimer's disease. , 2002, Controlled clinical trials.
[10] A. Hofman,et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. , 2001, The New England journal of medicine.
[11] Rong Wang,et al. A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity , 2001, Nature.
[12] Šimon Scharf,et al. A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer’s disease , 1999, Neurology.
[13] K. Saag,et al. Nonsteroidal Anti-Inflammatory Drugs and Cognitive Function , 1998, Drug safety.
[14] S. Rabe-Hesketh,et al. Do antiarthritic drugs decrease the risk for cognitive decline? An analysis based on data from the MRC treatment trial of hypertension in older adults. , 1998, Neurology.
[15] L. Ferrucci,et al. Protective Effect of Chronic NSAID Use on Cognitive Decline in Older Persons , 1996, Journal of the American Geriatrics Society.
[16] J H Shih,et al. Sample size calculation for complex clinical trials with survival endpoints. , 1995, Controlled clinical trials.
[17] A. Kaszniak,et al. Clinical trial of indomethacin in Alzheimer's disease , 1993, Neurology.
[18] J. Goodwin,et al. Cognitive dysfunction associated with naproxen and ibuprofen in the elderly. , 1982, Arthritis and rheumatism.